Establishment Labs (NASDAQ:ESTA) Rating Increased to Strong-Buy at Stephens

Stephens upgraded shares of Establishment Labs (NASDAQ:ESTA) to a strong-buy rating in a research report sent to investors on Monday morning,Zacks.com reports.

Several other equities research analysts have also issued reports on the stock. JPMorgan Chase & Co. reduced their target price on shares of Establishment Labs from $61.00 to $50.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. Citigroup increased their target price on shares of Establishment Labs from $45.00 to $50.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. Finally, BTIG Research increased their target price on shares of Establishment Labs from $62.00 to $65.00 and gave the stock a “buy” rating in a report on Monday, October 14th. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $60.60.

Establishment Labs Price Performance

NASDAQ ESTA opened at $44.17 on Monday. Establishment Labs has a 52 week low of $22.05 and a 52 week high of $60.12. The firm has a market capitalization of $1.24 billion, a P/E ratio of -17.12 and a beta of 1.16. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The company has a 50-day moving average price of $43.49 and a 200-day moving average price of $44.55.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Hood River Capital Management LLC bought a new position in shares of Establishment Labs during the 2nd quarter valued at approximately $43,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Establishment Labs in the third quarter worth $127,000. Nkcfo LLC purchased a new stake in Establishment Labs in the second quarter worth $227,000. SG Americas Securities LLC purchased a new stake in Establishment Labs in the second quarter worth $303,000. Finally, Black Swift Group LLC purchased a new stake in Establishment Labs in the third quarter worth $312,000. 72.91% of the stock is currently owned by institutional investors.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.